OpportunityTitle: Prescription Drug Overdose: Data-Driven Prevention Initiative (DDPI)
AdditionalInformationOnEligibility: State health departments or their bona fide agents. States receiving funding under Prescription Drug Overdose: Prevention for States (CE15-1501) or Prescription Drug Overdose: Boost for State Prevention (CE14-1404) are not eligible to receive funding under this FOA.
Description: The purpose of this funding is to advance and evaluate state-level prevention for opioid overuse, misuse, abuse, and overdose. The FOA advances a two-tiered strategy to allow for the fact that the needs of states vary considerably. Some states need support to build their ability to collect, analyze, and apply data and develop a strategy to combat the epidemic. These states may apply for the Planning and Data (base) component alone. Other states need resources and support to implement a comprehensive prevention program. These states may apply for both the Planning and Data component and the Prevention in Action (enhanced) component. States choosing the Planning and Data (base) component are expected to improve their data collection and analysis around the epidemic and work with their communities to develop a strategy for building a larger, more comprehensive program in the future. States choosing the advanced Prevention in Action (enhanced) component are expected to implement a prevention program and impact the behaviors driving prescription opioid dependence and abuse, and ultimately reduce the negative health consequences (e.g., ED visits, overdose deaths) associated with prescription drug abuse.
GrantorContactEmailDescription: Grants Policy
GrantorContactText: Eric Gross&lt;br/&gt;euw9@cdc.gov&lt;br/&gt;
CloseDateExplanation: Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.